Technology Application Identification

Your tech is going to change the world -- but how? DeciBio’s team of life scientists knows why and how your technology creates value, and we’ll help you find exactly where to focus to demonstrate that to customers and the broader market.

Our Experts

Miguel Edwards

Stephane Budel

Andrew Aijian

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Clinical Diagnostics

NIPT Market Landscape and Strategy

A large multi-national diagnostic company was interested in understanding the market landscape and potential strategy for the decentralization of NIPT in the U.S.

View

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Go-to-Market Strategy

Pharma & Biotech

Biopharma Genomic Testing Market Research

A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx

View

Voice-of-Customer Research

Financial Services

CDD on Novel Handheld Diagnostic Device Manufacturer

A global healthcare investment firm wanted to perform a commercial due diligence (CDD) prior to investment in a company producing a novel handheld diagnostic.

View

Voice-of-Customer Research

KOL Identification

Pricing Strategy

Revenue Projection

Due Diligence

Clinical Diagnostics

Carrier Screening Landscape Assessment

A leading diagnostics player wanted an assessment of the current and future carrier screening landscape, primarily in the U.S., to guide their product development strategy

View

Voice-of-Customer Research

Clinical Diagnostics

RNA-based Oncology Biomarker Market Landscape

A cancer diagnostics company wanted to understand the current and future landscape for RNA-based oncology biomarkers, focusing on gene expression profiling (GEP) and rearrangements across medical settings

View

Voice-of-Customer Research

Competitive Analysis

Biomarker and Diagnostics Strategy

Product Specification Mapping

Clinical Diagnostics

Low-Throughput Molecular Diagnostic Testing Landscape Assessment

A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market

View

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch